Span Divergent share news and announcements
BSE: 524727Pharmaceuticals & BiotechnologySmall Cap
Last close ₹23.10up ₹1.10 (5.00%)
Share price at the BSE close on 22 Oct 2026. Previous close ₹22.00.
52-week range of traded prices to 22 Oct 2026
₹20.52Low, 8 Oct 2026₹51.49High, 1 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹17 Cr4,116th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 1.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- −24.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.73
- Volume, BSEVolume. Shares traded on the last trading day.
- 341
Span Divergent share news and announcements
582 announcements, routine notices left out, newest first. Page 11 of 12.
May 2014
15 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 23, 2014, inter alia, to consider and approve the following: 1. ....
Apr 2014
17 Apr · Shareholding Pattern For March 31, 2014
Mar 2014
11 Mar · Board Meeting on March 21, 2014
Meeting of the Board of Directors of the Company will be held on March 21, 2014, inter alia, to take note of the voting results of Postal Ballot ....
Feb 2014
Jan 2014
25 Jan · Board Meeting on Feb 04, 2014
Meeting of the Board of Directors of the Company will be held on February 04, 2014, inter alia, to consider & approve the issue of Notice of ....24 Jan · Transfer of In-vitro Diagnostics business to Arkray Healthcare Private Limited
On January 24, 2014 the Company has executed an agreement for transfer of its In-vitro Diagnostics business to Arkray Healthcare Private Limited ....23 Jan · Span Diagnostics unlocks significant shareholder value, Transfers in-vitro diagnostics business to ARKRAY Healthcare Private Limited
Oct 2013
Aug 2013
Jul 2013
27 Jul · Board meeting
Board of Directors of the Company at its meeting held on July 27, 2013, inter alia: 1. Approved resignation of Mr. Mitesh Rana as Company ....
May 2013
28 May · Intimation of Sell of Investment in Subsidiary Company
Company has sold its entire shareholding held in Subsidiary Company namely M/s. Span Biotherapeutics Private Limited and accordingly the relation ....21 May · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from July 18, 2013 to July 27, 2013 (both days inclusive) for ....15 May · Board meeting
Board of Directors of the Company at its meeting on May 15, 2013, inter alia, has transacted the following: 1. Approved the reappointment ....15 May · Dividend
Board of Directors of the Company at its meeting held on May 15, 2013, inter alia, has recommended dividend of Re. 0.50 per equity share of ....2 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 15, 2013, inter alia, to consider and approve the following : 1. ....
Apr 2013
17 Apr · Results
Company opts for publication of audited financial results for the year ended March 31, 2013 within a period of sixty days that is before May 30, 2013. ....
Mar 2013
Feb 2013
8 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 08, 2013, inter alia, has approved the following : 1. The Board has ....
Nov 2012
Aug 2012
8 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 08, 2012, inter alia, has transacted the following : 1. Elected Mr. ....
May 2012
28 May · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from July 30, 2012 to August 08, 2012 (both days inclusive) for ....26 May · Board meeting
Board of Directors of the Company at its meeting held on May 26, 2012, inter alia, has transacted the following: - In view of Company's ....15 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 26, 2012, inter alia, to consider and approve the following: 1. ....
Apr 2012
17 Apr · Results
Company opts for publication of audited financial results for the year ended March 31, 2012 within a period of sixty days that is before May 30, 2012. ....
Mar 2012
26 Mar · Prestigious Order received by the Company
Company has received a prestigious order worth Rs. 21.45 Crores from Ministry of Health & Family Welfare, Department of AIDS Control. National ....26 Mar · Board meeting
Board of Directors of the Company at its meeting held on March 24, 2012, inter alia, has approved the following: 1. The Board has approved ....16 Mar · Board Meeting on March 24, 2012
Meeting of the Board of Directors of the Company will be held on March 24, 2012 inter alia, to consider terms of remuneration to managerial personnel.
Feb 2012
Jan 2012